{"version":"1.0","type":"link","title":"Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities.","author_name":"Kır S 외","author_url":"https://prs-insight.online/author/K%C4%B1r%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/158595","thumbnail_width":1200,"thumbnail_height":630}